Blog / Archives
Global Recession Fears Dominate Market: Safety in Biotechnology and Large Cap Drug Stocks
Got Gold and U.S. Treasuries? It is impossible to really describe the market turmoil in the space below so let this post from Investor Uprising suffice. With 10 Year treasuries under 2% and Gold...
Sell-Off Resumes as European Debt Crisis Gets Headlines
No Eurobond and Possible Financial Transaction Tax NASDAQ down 0.9% % and S&P down 0.7 % as Bear Returns but Off Session Lows Earlier in Trading The three day stock market rally is on hold for...
Q2 Review of Pure Play Diagnostic Companies:Bargain Hunting in ABAX,GPRO,QGEN
Summary of Q2 Earnings and Valuation Metrics of Selected Pure Play Dx Companies Company Ticker Price RevEst Q1Rev Q2Rev Price Mcap P/S PE PEG 5/18/11 $M Yr. $M 15-Aug $M GenProbe GPRO 80 579 143 136...
Eurozone Crisis Creates More Fear and a Vicious Sell-Off
Global Debt Crisis Weighs In-Everything is Interconnected Panic selling has eased after European market closes but we are still down 3%. 10 Year treasuries are under 2.5%.Banks cannot handle the...
Wild Turnaround Day- RoboTraders Again?
Time to Follow the Technicals If you missed the morning action today you were better off unless you were bargain hunting. It looked like another ugly free-fall day at about 10 am EDT until some...
Sell Off in the Eighth Day but Look to AMGN and GPRO for Help
Classic Risk-Off Market With 10 Year Yield at 2.6%-Healthcare Sector Still Selling Off Down 1.68% The market is not celebrating the Debt-Limit Deal. A new reality may be setting now that all the...
Debt Deal: Healthcare Stocks Sell Off On Potential Medicare Cuts
Triggers: Debt Ceiling and Skilled Nursing Stocks There is a broad sell-off in healthcare stocks today on fears that the debt ceiling deal would cut healthcare spending.A few weeks ago a few hedgies...
Data Shows How Dx Companies Are Growing Through M&A
Here is 2011 Deal Data from IVDnews.com one of the leading data and news sites covering Diagnostics. Contact IVD News for details on all IVD deals for 2011. Recent M&A examples from our focus...
Rayno Life Science Tools and Diagnostics: What’s Hot and Not?
It was a tough week in Life Science Tools and Diagnostics with many crosscurrents: debt ceiling uncertainty, earnings shortfalls, lackluster economic data and European debt crisis. The usual...
Nice Snapback Rally in Life Science Today-ILMN Up 3.93%, Abaxis (ABAX) Leads Up 5%
Rayno Life Science Portfolio Recovers Up 1.73%; Jobless Claims Help The thrashing of Illumina (ILMN) yesterday appears to be overdone as the stock is recovering to the $60 area on volume of over...